Introduction: Joints of persons with hemophilia are frequently affected by repetitive hemarthrosis. In this paper, concepts, perks, and quirks of the use of artificial intelligence (AI), machine learning (ML), and deep learning are reviewed within clinical and research contexts of hemophilia and other blood-induced disorders' patient care, targeted to the imaging diagnosis of hemophilic joints, under the perspective of different stakeholders (radiologists, hematologists, nurses, physiotherapists, technologists, researchers, managers, and patients/caregivers).
Areas covered: Rubrics that determine the suitability of the utilization of AI in blood-induced disorders' patient care, including diagnosis and follow-up of patients are discussed, focusing on features in which AI can replace or augment the role of radiology in the clinical management and in research of patients. Insights on features in the design and conduct of AI projects in which the human intervention remains critical are provided.
Expert opinion: The author discusses research concepts in radiogenomics, and challenges for the utilization of AI in different healthcare fields such as patient safety, data sharing and privacy regulations, workforce education and future jobs' shortage. Finally, the author proposes alternatives and potential solutions to mitigate challenges in successfully deploying ML algorithms into clinical practice.
Keywords: Artificial intelligence; arthropathy; augmentation; hemophilia; imaging; joints; machine learning; radiogenomics; regulations.